[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.161.30. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
February 15, 2006

Obesity Research—Limitations of Methods, Measurements, and Medications

Author Affiliations
 

Author Affiliations: Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, Md.

JAMA. 2006;295(7):826-828. doi:10.1001/jama.295.7.826

Obesity is one of the most important public health problems today. An estimated 65% of US adults are overweight or obese,1 with 112 000 to 280 000 annual deaths attributable to obesity.2,3 If trends continue, obesity-related deaths may lead to cessation of the increases seen in life expectancy and perhaps to reduced life expectancy in the future,4 and obesity will contribute even more adversely to the population's well-being and health care costs in the United States.5

First Page Preview View Large
First page PDF preview
First page PDF preview
×